美疾控中心:辉瑞疫苗接种后已报告21起过敏反应

2021-01-07 谭晶晶 新华社

美国疾病控制和预防中心6日发布的一份报告显示,截至2020年12月23日,全美共有1893360人接种了第一剂辉瑞新冠疫苗,共报告了4393起不良反应事件(不良反应率约为0.2%),其中包括21起过敏

美国疾病控制和预防中心6日发布的一份报告显示,截至2020年12月23日,全美共有1893360人接种了第一剂辉瑞新冠疫苗,共报告了4393起不良反应事件(不良反应率约为0.2%),其中包括21起过敏反应。

美国食品和药物管理局2020年12月批准了美国辉瑞制药有限公司与德国生物新技术公司联合研发的新冠疫苗的紧急使用授权申请。这是第一款获批在美紧急使用的新冠疫苗,被允许用于16岁及以上人群,共接种两剂,间隔21天。

据美疾控中心和美药管局网站介绍,这款疫苗在此前的临床试验中出现的不良反应包括接种部位局部红肿、头痛、乏力等。美国、英国等开始接种这一疫苗后,报告的数起过敏反应备受关注。此前英国药品监管机构曾表示,已向相关卫生机构发出预防性建议,任何人如果曾有“显着”的药物、食物或疫苗过敏反应,都不应接种该疫苗。

美疾控中心在6日的报告中说,新冠疫苗接种点需要严格遵循美疾控中心对新冠疫苗接种的相关要求,包括筛查接种禁忌、做好应对过敏反应的必要准备、对疫苗接种者接种后情况进行观察等。

目前,共有两款新冠疫苗获美药管局批准紧急使用,除了辉瑞与德国生物新技术公司联合研发的疫苗外,另一款由美国莫德纳公司研发。这两款疫苗已分发至全美各地,优先为医护人员和生活在养老院等长期护理机构的人群接种。

美疾控中心网站疫苗数据显示,截至2021年1月6日,已有近1728.9万剂疫苗分发至全美各地,接种第一剂疫苗的人数约为530.6万。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1659258, encodeId=281516592583f, content=<a href='/topic/show?id=ce25e997691' target=_blank style='color:#2F92EE;'>#美疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79976, encryptionId=ce25e997691, topicName=美疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=488a24942665, createdName=zhenjiu131, createdTime=Fri Dec 03 19:50:26 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257917, encodeId=a954125e917be, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Jan 09 13:50:26 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336644, encodeId=27c013366448f, content=<a href='/topic/show?id=543794035c9' target=_blank style='color:#2F92EE;'>#过敏反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94035, encryptionId=543794035c9, topicName=过敏反应)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKeia4TJeMGvEH3wKKIBNjuHuIic1HDNOB10j4tCd3nbylxkxm6HSMfEaKkSu6OZOak4uZv7UVicsWEg/132, createdBy=bc9a2500116, createdName=zywlvao, createdTime=Sat Jan 09 13:50:26 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405368, encodeId=3746140536898, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Sat Jan 09 13:50:26 CST 2021, time=2021-01-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1659258, encodeId=281516592583f, content=<a href='/topic/show?id=ce25e997691' target=_blank style='color:#2F92EE;'>#美疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79976, encryptionId=ce25e997691, topicName=美疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=488a24942665, createdName=zhenjiu131, createdTime=Fri Dec 03 19:50:26 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257917, encodeId=a954125e917be, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Jan 09 13:50:26 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336644, encodeId=27c013366448f, content=<a href='/topic/show?id=543794035c9' target=_blank style='color:#2F92EE;'>#过敏反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94035, encryptionId=543794035c9, topicName=过敏反应)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKeia4TJeMGvEH3wKKIBNjuHuIic1HDNOB10j4tCd3nbylxkxm6HSMfEaKkSu6OZOak4uZv7UVicsWEg/132, createdBy=bc9a2500116, createdName=zywlvao, createdTime=Sat Jan 09 13:50:26 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405368, encodeId=3746140536898, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Sat Jan 09 13:50:26 CST 2021, time=2021-01-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1659258, encodeId=281516592583f, content=<a href='/topic/show?id=ce25e997691' target=_blank style='color:#2F92EE;'>#美疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79976, encryptionId=ce25e997691, topicName=美疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=488a24942665, createdName=zhenjiu131, createdTime=Fri Dec 03 19:50:26 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257917, encodeId=a954125e917be, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Jan 09 13:50:26 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336644, encodeId=27c013366448f, content=<a href='/topic/show?id=543794035c9' target=_blank style='color:#2F92EE;'>#过敏反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94035, encryptionId=543794035c9, topicName=过敏反应)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKeia4TJeMGvEH3wKKIBNjuHuIic1HDNOB10j4tCd3nbylxkxm6HSMfEaKkSu6OZOak4uZv7UVicsWEg/132, createdBy=bc9a2500116, createdName=zywlvao, createdTime=Sat Jan 09 13:50:26 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405368, encodeId=3746140536898, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Sat Jan 09 13:50:26 CST 2021, time=2021-01-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1659258, encodeId=281516592583f, content=<a href='/topic/show?id=ce25e997691' target=_blank style='color:#2F92EE;'>#美疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79976, encryptionId=ce25e997691, topicName=美疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=488a24942665, createdName=zhenjiu131, createdTime=Fri Dec 03 19:50:26 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257917, encodeId=a954125e917be, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Jan 09 13:50:26 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336644, encodeId=27c013366448f, content=<a href='/topic/show?id=543794035c9' target=_blank style='color:#2F92EE;'>#过敏反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94035, encryptionId=543794035c9, topicName=过敏反应)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKeia4TJeMGvEH3wKKIBNjuHuIic1HDNOB10j4tCd3nbylxkxm6HSMfEaKkSu6OZOak4uZv7UVicsWEg/132, createdBy=bc9a2500116, createdName=zywlvao, createdTime=Sat Jan 09 13:50:26 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405368, encodeId=3746140536898, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Sat Jan 09 13:50:26 CST 2021, time=2021-01-09, status=1, ipAttribution=)]
    2021-01-09 zutt

相关资讯

美疾控中心提醒农产品交易时应预防猪流感

由于人感染新型“猪流感”病毒菌株病例的上升,美国疾病控制与预防中心(CDC)要求出入农产品展销会并与猪有接触的人们采取一定的防护措施。他们力劝,特别是易感染人群,例如病人、5岁以下儿童、孕妇及老年人,应避免同此类动物接触。在8月3日发布的报告中,联邦机构称,新近感染猪流感病毒菌株的病例已达12例,而这种病毒菌株通常是在猪之间传播的。自2011年以来,实验室确认感染这一新型变种甲型流感病毒(H3N2

五位美国疾控中心前主任批评政府抗疫不力

美国广播公司当地时间8月6日采访了5位美国疾病控制和预防中心的前主任,这5人在美国疾控中心任职期间,都曾经历过艾滋病、炭疽、非典、禽流感或埃博拉等公共卫生危机,而在此前的疫情防控中,美国疾控中心一直都